Toll-like receptor (TLR) 13 and TLR2 are the major sensors of Gram-positive bacteria in mice. TLR13 recognizes Sa19, a specific 23S ribosomal (r) RNA-derived fragment and bacterial modification of Sa19 ablates binding to TLR13, and to antibiotics such as erythromycin. Similarly, RNase A-treated Staphylococcus aureus activate human peripheral blood mononuclear cells (PBMCs) only via TLR2, implying single-stranded (ss) RNA as major stimulant. Here, we identify human TLR8 as functional TLR13 equivalent that promiscuously senses ssRNA. Accordingly, Sa19 and mitochondrial (mt) 16S rRNA sequence-derived oligoribonucleotides (ORNs) stimulate PBMCs in a MyD88-dependent manner. These ORNs, as well as S. aureus-, Escherichia coli-, and mt-RNA, also activate differentiated human monocytoid THP-1 cells, provided they express TLR8. Moreover, Unc93b1 À/À -and Tlr8 À/À -THP-1 cells are refractory, while endogenous and ectopically expressed TLR8 confers responsiveness in a UR/URR RNA ligand consensus motif-dependent manner. If TLR8 function is inhibited by suppression of lysosomal function, antibiotic treatment efficiently blocks bacteria-driven inflammatory responses in infected human whole blood cultures. Sepsis therapy might thus benefit from interfering with TLR8 function.
Introduction
Toll-like receptors (TLRs) mediate recognition of pathogen-and host-derived "danger associated molecular patterns" (P-/DAMPs) driving severe inflammation such as in sepsis, which is mostly induced by Gram-positive and Gram-negative bacterial infection [1] . Anti-inflammatory interventions in the acute sepsis phase are thus promising therapeutic approaches [2] . Indeed, blockade of TLR2 and TLR4 at the start of antibiotic therapy inhibited human peripheral blood mononuclear cell (PBMC) activation and also saved mice upon Gram-negative but not Gram-positive bacterial infection [3] . Accordingly, the Sa19 segment of bacterial 23S ribosomal (r) RNA is a murine (m) TLR13 ligand strongly operative primarily in Gram-positive bacterial infection [4] [5] [6] [7] . Sa19 sequence modification, as is frequently found in methicillin-resistant Staphylococcus aureus (MRSA) strains that are also macrolide, lincosamide and streptogramin antibiotic (MLS) resistant, ablates recognition by TLR13 (termed immune escape) [5, 8] . On the other hand, bacterial transfer (t) RNA is recognized via TLR7, and Gram-negative bacterial RNA activates human (h) TLR8 [9] [10] [11] . Whether Gram-positive bacterial RNA drives a strong immune activity immediately upon acute infection also in humans as it had been observed in mice is largely unknown. Previous studies searching for a human pattern recognition receptor (PRR) equivalent to mTLR13 have concluded that mainly TLR2 is operative in response to Gram-positive bacteria [5, 12] .
Here, we demonstrate that not only Sa19, but also variants of it including mitochondrial (mt) 16S rRNA-borne derivatives strongly stimulate human immune cells via TLR8 exclusively. Ligand recognition of TLR8 was found to be promiscuous, in that its ligand consensus motif was broader than "UGG" [13] , since "UAA" and "UGA" motifs were also activating. Human TLR8 thus senses both bacterial pathogen-derived rRNAs and self-mitoribosomal (mtr) RNA wherein the latter descends from bacteria according to the endosymbiotic theory. Specifically, we observed that TLR8-mediated RNA sensing is critically involved in recognition of viable Escherichia coli and S. aureus. For example, the inhibition of lysosomal function, which affects bacteria-driven TLR8 and also TLR7 activation, allowed antibiotics to inhibit consequent inflammation. Our results identify TLR8 as major bacteria and mitochondria sensor and implicate a novel therapeutic interference in acute inflammation pathology.
Results and Discussion
Specific bacterial and mitochondrial RNAs activate human immune cells dependent on MyD88 and Unc93B1 but largely independent on TLR7
In quest for a human equivalent of TLR13, we analyzed whether the 23S rRNA segment Sa19-with 19 bases of appropriate length [14] -or heat-inactivated S. aureus (hiSa) stimulate PBMCs. Both compounds were active. Thus, blockade of TLR2 with a neutralizing and human/mouse cross-reactive monoclonal antibody (mAb, named T2.5) was ineffective unless the hiSa solution was incubated with single-stranded (ss) RNA-specific RNase A (Fig 1A) [5, 15] . We thus concluded that both Sa19 "like" ssRNA segments as well as TLR2 ligands are candidates of S. aureus-derived immune stimulatory PAMPs.
Also, self-RNA-antimicrobial peptide complexes stimulate human dendritic cells (DCs) via TLRs and the endosymbiotic theory implies that self-mitochondria originate from bacteria [16, 17] . Since 23S bacterial rRNA comprises Sa19, we analyzed the sequence of its 16S mtrRNA human, cattle, mouse and rat orthologs and designed specific 19-mer Sa19 "like" oligoribonucleotides (ORNs, Figs 1B and EV1A and B). The 16S mtrRNA Sa19 orthologous segment termed *mtPTL, like Sa19 located within domain V of the large rRNA is conserved yet mutated toward "GAGAAGA", while integer Sa19 "GGAAAGA" motifs are contained in other regions of 16S mtrRNAs [18] . We also used two Sa19 adenosine (A) 7 variants that lack murine immune cell stimulatory capacity (Figs 1B and EV1C and D) [5, 7] . None of the Sa19 "like" RNA segments applied activated mTLR13, and only *mtPTL carrying a TLR7-prone "UAU" motif 
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-P Anne Krüger et al HuTLR8: a major sensor of bacterial and mitochondrial RNA EMBO reports activated the murine immune system at all and through TLR7 (Fig EV1C-H) [14, 19] . Total mtRNA was refractory (Fig EV1D) , as if *mtPTL was rendered inactive in the context of total mtRNA. This finding was reminiscent of TLR13 "muteness" toward the E. coli Sa19 within total RNA [5] . We next analyzed human PBMCs for their responsiveness to different bacteria and self-derived RNAs. While all Sa19 "like" ORNs applied including TLR13-silent, point-mutated, and methylated ones induced robust TNF production in PBMCs, surprisingly none triggered substantial type I interferon (IFN) release (Fig 1C) . This result indicated a lack of TLR7 involvement because TLR7 ligands such as RNA40 and bacterial tRNA induce PBMC type I interferon (IFN) production by activating plasmacytoid DC TLR7 [14, 19] . Next, we analyzed bacterial rRNA activities (Fig EV2A) [5, 9, 10] . 23S, 16S, and 5S rRNA of both Gram-positive and Gram-negative bacteria induced substantial TNF release from PBMCs, provided their lysosomes were functional ( Fig 1D) . While total bacterial RNA encompassing tRNA triggered substantial IFNa release, neither bacterial rRNAs, nor total mtRNA hardly induced IFNa release, while the latter RNA elicited strong IL-6 production (Figs 1E and F, and EV2B).
PBMCs of a human individual expressing a nonfunctional Glu53D MyD88 mutant [20] failed to respond to S. aureus RNA and to Sa19 "like" ORNs ( Fig 1G) . Given that 3-day differentiated (3ddi) THP-1 cells turned out to be responsive toward Sa19 (Fig 1H) , we applied THP-1 cells lacking expression of Unc93B1 (a chaperon translocating TLRs from the endoplasmic reticulum to endosomes) [21, 22] . Like undifferentiated and 8ddiTHP-1 cells, Unc93b1 À/À -3ddiTHP-1 counterparts failed to respond toward Sa19 "like" ORNs ( Fig 1I) .
Upregulation or overexpression of TLR8 confers uridine-dependent specific bacterial and mitochondrial RNA responsiveness while TLR8 knockout abrogates it
Unc93b1
À/À -3ddiTHP-1 cells were also insensitive to large bacterial rRNAs (Fig 2A) [12] . However, they responded well to hiSa and E. coli (Ec) via TLR2 (Fig 2B and C) . Next, we comparatively profiled transcriptomes of undifferentiated, 3ddi-, and 8ddiTHP-1 cells. Selection of non-interleukin receptors that were at least twofold upregulated on the mRNA level in 3ddiTHP-1 cells led to seven candidate molecules out of which we considered mTLR13-like TLR8 as most promising candidate (Figs 2D and EV2C). In contrast to mTLR13, hTLR8 carries a z-loop ( Fig EV2D) providing a functionally important cleavage site that contributes to ligand binding, and is deleted in mTLR8 [13] . In order to substantiate our selection of hTLR8, we analyzed its "gain and loss of" function. All Sa19 "like" ORNs activated hTLR8 overexpressing HEK293 cells, and BtmtD3_4 triggered also mRAW264.7 cell activity through hTLR8 (Fig 2E  and F) . Furthermore, knockdown of TLR8 mRNA abrogated responsiveness to BtmtD3_4, and to R848 (Figs 2G and EV2E) .
Moreover, responsiveness of Tlr8 À/À -3ddiTHP-1 cells to specific ORNs and bacterial rRNAs was strongly impaired, while total bacteria RNA recognition was widely operative (Fig 3A and B) [22] . Otherwise, their sensitivity for hiSa and hiEc was normal, but largely TLR2 driven ( Figs 3C and EV2F) . Sensing of imidazoquinoline R848 and the guanosine (G) nucleotide analogue loxoribine by TLR7 was weak in Tlr8 À/À cells yet abrogated by TLR7 mRNA expression knockdown (Figs EV2F and G, and EV3A) [19, 23] .
Besides loxoribine and RNA40, only total bacterial RNA and to a low degree also S. aureus 5S rRNA triggered IFNa release by PBMCs, which emphasized TLR8 specificity and lack of TLR7 specificity of the ORNs, bacterial rRNAs, as well as mtRNA (Fig 1C, E , and F) [14] . Of note, mtRNA-driven activation of 3ddiTHP-1 cells was absent from Tlr8 À/À and Unc93b1 À/À -3ddiTHP-1 cells (Fig 3D) .
TLR7 and most likely also TLR8 preferentially bind U/G rich viral-, si-, and self-RNA [14, 19, [23] [24] [25] . Structural data imply that the RNA specificity of TLR8 might be guided by the U and G content of ssRNA [13] . We thus transfected Sa19 "like" ORNs differing in their U content (Fig 1B) and admixed U nucleosides into TLR8 + cells. The stimulatory power of ORNs that contained sparse U (such as Sa19 and Sa19 point mutants) substantially became enhanced by co-application of U nucleoside. Notably, ORN HsmtD1 containing like Sa19 just one U strongly activated cells. U-less Sa12 containing a CGG motif failed to activate TLR8, while its mutant Sa12s6U carrying an A6U mutation resulting in containment of a UAA motif, included in duplicate in BtmtD3_4, while HsmtD1 carries a UGA motif, strongly activated cells (Fig 3E-H) . Our data imply UR/URR rather than mere UG/UGG as RNA ligand consensus motif (Figs 3F and H, and EV3B) [13] .
Bacterial infection-driven cell activation is TLR8 dependent and inhibited by chloroquine in whole blood Next, we explored the impact of hTLR8 on protective interventions during infection. To test this, THP-1 cells pretreated with TLR2 neutralizing mAb were seeded with viable S. aureus, or with E. coli.
In Tlr8
À/À -3ddiTHP-1 cells, inhibition of activation by TLR2 blockade was substantial (Fig 4A) . Furthermore, a combination of chloroquine-a broadly established lysosomal function inhibitorand T2.5 pretreatment significantly impacted PBMCs. Specifically, a contribution of TLR2 to both, TNF and IFNa production upon Grampositive bacteria-driven activation, was barely detectable since chloroquine alone was efficient, which was true also for Gramnegative bacterial infection in respect to IFNa but not TNF release ( Figs 4B and EV3C ). The failure of the control stimulus (and TLR8 ligand) BtmtD3_4 to induce substantial IFNa production while triggering that of TNF to similar degrees as compared to both infections implicated involvement of further endosomal pattern recognition in bacterial infections such as of tRNA through TLR7 (Figs 4B and EV3C). Also within whole blood, chloroquine inhibited TNF release more strongly upon infection with Gram-positive bacteria as compared to infection with Gram-negative bacteria, while its impact on IL-6 production (strongly induced by lipopeptide/TLR2) was the opposite (Figs 4C and EV3D) . Altogether, these data imply TLR8 as one major bacteria-and self-mitochondria sensor and hint at an anti-inflammatory potential of TLR8 blockade in sepsis. Whether this potential extends toward other clinical syndromes, such as trauma-induced sterile inflammation, or autoimmunity, remains to be evaluated.
Perspective and concluding remarks
Upon submission of this study, four reports on Gram-positive bacterial RNA sensing by hTLR8 or on mTLR13 structure have been published and largely summarized [26] [27] [28] [29] [30] . Thus, S. aureus as well as Streptococcus pyogenes and Streptococcus agalactiae and Listeria
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monocytogenes total RNAs activate hTLR8 but not TLR7 [26, 28] . Total RNAs of further Gram-positive and probiotic bacteria, as well as Enterococcus faecalis (EC-12)-derived 23S and 16S rRNA drive TLR8-dependent, yet TLR7-independent IL-12 production [27] . Our results extended these and earlier findings by implicating 5S beyond 23S and 16S rRNA of S. aureus and also Gram-negative E. coli as well as mtrRNA as immune stimulatory P-/DAMPs that activate hTLR8 with their UR/URR motif segments [11, 13] . Function restricting TLR8 mutation in mice might underlie their TLR13 expression and thus the A7 methylation mediated Sa19 camouflage, which is inoperative in other tetrapodes including human, macaque, and hog ( Figs 1C, EV3E and EV4 ). Evolvement of Ratios of constitutive mRNA amounts in 3-versus 8ddi (gray bar) and of each of both versus undifferentiated THP-1 cells (black or white bar, respectively) according to a transcriptome profiling result (n = 1). E, F NF-jB-driven relative luciferase activity (Rel. luc. act.) of hTLR8-overexpressing HEK293 and murine RAW264.7 cells, respectively, upon challenges (vector, empty plasmid; n = 3). G Transfection of TLR8 siRNA impairs 3ddiTHP-1 cell responsiveness (n = 3).
Data information: Graphs show mean AE SD; *P ≤ 0.05; **P ≤ 0.01; unpaired t-test; -, unchallenged; P 3 C, Pam 3 CSK 4 ; n.d., not detected; Sa, S. aureus; Ec, E. coli. Anne Krüger et al HuTLR8: a major sensor of bacterial and mitochondrial RNA EMBO reports TLR8 as a bacteria sensor might have resulted from perpetuating confrontation with either soil bacteria producing an MLS antibiotic, or bacteria expressing resistance conferring methyltransferase only, or bacteria carrying a respective 23S rRNA mutation upon fishtetrapod evolutionary transition [31] . Since immune escape of such bacteria could have handicapped host survival, promiscuous ssRNA sensing via TLR8 is of advantage. The price to be paid, however, is reactivity toward endogenous ssRNA with which the immune system of hTLR8 transgenic mice can hardly cope [32, 33] .
Materials and Methods

Materials
RNase A, phorbol 12-myristate 13-acetate (PMA), U nucleosides, chloroquine, and gentamicin were applied at 20 lg/ml, 200 nM, 5 mM, 5 or 20 lg/ml (PBMCs or whole blood, respectively), and 10 lg/ml respectively (all Sigma). Cells were pre-incubated for 30 min for TLR2 blockade with 20 lg/ml T2.5 [3] (Hycult Biotech). Pam 3 CSK 4 was applied at 0.1 lg/ml (EMC Microcollections). LPS (0111:B4), CL075, RNA40, loxoribine, and R848 were applied to cells at 0.1 or 1 lg/ml (human or murine cells, respectively), 2.5 lg/ml, 0.5 lg/ml, 600 lM, and 10 or 5 lg/ml (human or murine cells, respectively), respectively (all Invivogen). ODN 1668 was applied at a concentration of 10 lM (MWG).
Bacterial challenges
HiSa and hiEc were applied at concentrations of 1 × 10 8 , 10 7 , and 10 6 cfu/ml or a concentration of 1 × 10 7 cfu/ml only. The hiSa solution was incubated with RNase A for 1 h at 37°C wherein the 37°C incubation alone did not abrogate the stimulation capacity [5] . THP-1 cells were infected with 1 × 10 8 , 10 A Cytokine release of 3-day differentiated THP-1 cells of the indicated genotypes upon TLR2 blockade (T2.5) and challenge with TLR ligands, heat-inactivated (hi) or viable bacteria. B PBMC activity upon endosome function inhibition (chloroquine) and TLR2 blockade (T2.5) followed by TLR ligand challenge or bacterial infection. C Activity of whole blood culture upon endosome function inhibition (chloroquine) and challenge with TLR ligands, heat-inactivated (hi), or viable bacteria.
Data information: Graphs show mean AE SD; n = 3; *P ≤ 0.05; **P ≤ 0.01; unpaired t-test; -, unchallenged; P 3 C, Pam 3 CSK 4 ; n.d., not detected; triangles, decreasing doses of exponentially growing bacteria gentamicin-treated 1 h post-infection. 3 , and 1 × 10 3 cfu/ml of E. coli, and whole blood with 1 × 10 7 , 10 6 , and 10 5 cfu/ml of S. aureus and 1 × 10 6 , 10 5 , and 10 4 cfu/ml of E. coli. After 1 h, gentamicin was added to stop bacterial growth [3] .
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Cell culture BM or splenocytes from mice and PBMCs generated from humans of wt genotype if not indicated otherwise as well as RAW264.7 (murine macrophagoid), HepG2 (human hepatocytoid), THP-1 (human monocytoid), and HEK293 (human fibroblastoid) cell line cells were grown under regular cell culture conditions [3] . THP-1 cells were differentiated with PMA (1 × 10 7 cells/96-well plate) for either 24 h followed by 3 days culture in PMA-free medium (3ddi), or 72 h followed by 5 days culture in PMA-free medium (8ddi). Whole blood was drawn into monovettes (Braun, 8 ml) prefilled with Bivalirudin (5.3 mg) and aliquoted in 200 ll portions [34] . Blood was drawn and PBMCs generated from buffy coats (provided by P. Horn) upon approval by the local ethics committee from healthy donors (14-5804-B0, University Hospital Essen) and from a patient expressing a nonfunctional Glu53D/157_159DGAG MyD88 mutant, approved through ethics vote of the local committee (282/11, University of Freiburg, Germany).
Bacteria
S. aureus (DSMZ 20231) and a clinical isolate clone of E. coli [3] were used for infections and challenges as heat-inactivated bacteria in vitro or in vivo, or as sources of RNA preparations used for cell challenges by their transfection. Bacteria were inoculated with 16-h-grown preparatory cultures (agitation, 37°C, E. coli in LB, S. aureus in BHI medium). In the logarithmic growth phase, bacteria were pelleted and collected in PBS for RNA preparation, heat inactivation 100°C, 15 min), or infection. Bacterial samples (taken immediately prior to inactivation) were titrated by plating.
Cytokine measurement and immunoblot analysis
Enzyme-linked immunosorbent assay (ELISA, human IL-8, IL-6, and TNF, used also for macaque samples, mouse IL-6, TNF, and KC all R&D, capture and detection antisera aswine IL-6, Bethyl Laboratories, recombinant swine IL-6, Kingfisher Biotech Inc.) and luminex or ELISAs (eBioscience) for human IFNa were performed according to the manufacturer's instructions. Supernatants from murine BMs and splenocytes or THP-1 cells (human) were sampled for ELISA 16 h after challenge start, while those of human PBMCs and whole blood were sampled after a 24-h time period.
Mitochondria and subsequent mtRNA preparation
Liver was harvested from Wistar rats. Tissue as well as harvested cultured HepG2 cells was homogenized in ice-cold isolation buffer (2 mM Hepes, 220 mM mannitol, and 70 mM sucrose, pH 7.4). Homogenized suspension was spun at 494 g (Sorvall ST16 cell centrifuge) for 3 min at 4°C. Supernatant was transferred to a fresh tube and spun. This washing step was repeated twice. Clear supernatant was spun at 26,000 g for 10 min at 4°C. Pellet was resuspended in ice-cold isolation buffer, and the centrifugation step was repeated twice which resulted in a pure mitochondria preparation. Pellets were resuspended in TRI reagent (Sigma) for RNA isolation (as described before [5] 
TLR8 mRNA knockdown
Forty-eight hours upon differentiation, THP-1 cells were transfected with siRNA (Qiagen) toward human TLR8 (ID SI02642458) as well as scrambled variant (ID 1027280, negative control). Lipofectamine RNAiMAX Transfection Reagent (Life Technologies) was used according to the manufacturer's instructions. Twentyfour hours post-transfection cells were challenged with stimulants in fresh medium. Supernatants were analyzed by ELISA. RNA was isolated and analyzed via RT-PCR as described before [5] . The primers used for PCR were (MWG eurofins) as follows: 18S rRNA, (sense) 5
TLR8 knockout
Tlr8
À/À -THP-1 cells were generated using the CRISPR/Cas9 technology as previously described [22] . In brief, cells were transfected with two plasmids encoding a CMV-mCherry-Cas9 expression cassette and a U6 promoter-driven sgRNA, respectively, by electroporation. The CRISPR target site used for TLR8 was AGGTCAGC ATTGACGACTGAAGG. THP-1 cells expressing mCherry-Cas9 upon electroporation were enriched by FACS sorting and cloned by limiting dilution. Two weeks later, single-cell clones were picked and expanded. Of these clones, genomic DNA was extracted and subjected to a first-level PCR using the following primer pair: (TLR8 gene-specific sequences in bold, Illumina adapter sequences underlined). In second-level PCRs, barcode primers unique for individual clones were used and PCR products were subjected to deep sequencing using the MiSeq (Illumina) benchtop sequencing system. Raw sequencing data were analyzed by applying the online tool OutKnocker.org and cell clones harboring out-of-frame mutations within the TLR8 gene were identified.
Gene array
For gene expression analysis of undifferentiated versus 3ddi versus 8ddiTHP-1 cells, RNA was prepared using TRI reagent (as described before [5] ) from cells analyzed in parallel for their Sa19 responsiveness (Fig 1H) . Total RNA concentration and purity were measured with a NanoDrop 1000 spectrophotometer (NanoDrop Technologies/Thermo Scientific). RNA integrity was assessed using an Agilent Bioanalyzer nano chip. Biotinylated cRNA was prepared according to the Affymetrix ExpressKit protocol starting from 200 ng total RNA. Following fragmentation, 10 lg of cRNA was hybridized for 16 h at 45°C on GeneChip HG-U133Plus_2. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix hybridization, wash, and staining Kit. Arrays were scanned in a GeneChip 3000 scanner with G7 update. The data were analyzed with MAS5 using Affymetrix default analysis settings and global scaling to a target intensity of 1,000 as normalization method. The microarray data from this publication have been submitted to the NCBI GEO database http://www. ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67264.
Reporter gene assay
Murine TLR13 and human TLR8 expression plasmids were transfected together with luciferase reporter plasmids into HEK293 cells for analysis of NF-jB-driven firefly and constitutive renilla luciferase activities upon calcium phosphate precipitation, as previously described [5] . RAW264.7 cells were transfected with the same plasmids using TurboFect (Life Technologies) following the manufacturer's instructions. 16 h after challenge, cell lysate was analyzed for luciferase activity (96-well plate Berthold luminometer).
Statistics
Results were analyzed for statistical significance using the Student's t-test for unpaired samples. Each illustrated column represents mean AE SD (error bars) of triplicate data points except for whole blood experiments results of which are represented by duplicate data points.
Further Methods are described in the Appendix Supplementary Methods.
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